TRANSVAC Funding of SPORCOVAX, SporeGen's Mucosal Vaccine to COVID-19 September 14, 2021 SporeGen Read More
SporeGen® receives GRAS Notice No. GRN 000905 from the FDA for its probiotic SG188 June 10, 2020 SporeGen Latest News Read More
Ownership Assignment of Bacillus Strains from Royal Holloway, University of London February 13, 2017 SporeGen Latest News Read More
SporeGen® is assigned ownership of two important probiotic strains from Royal Holloway, University of London February 28, 2017 SporeGen Read More
